View all veterinary jobs
VetSurgeon.org publishes a curated feed of veterinary news for practising veterinary surgeons, with a primary focus on the UK profession.
We select stories based on their practical relevance, clinical interest, or professional significance — filtering out noise so busy vets can stay informed quickly.
Our coverage includes:
We report across all areas of practice, including companion animal, farm, equine and exotic species.
Our editorial approach is deliberately selective and concise. We prioritise clarity and relevance over volume, aiming to make each story worth your time.
You can follow VetSurgeon News by subscribing to the daily, weekly or monthly email digest, or via our channels on Facebook and LinkedIn.
Jonathan Hill (UK Country Manager) said: “I’m delighted to announce that TVM UK is changing its name to Dômes Pharma.
"This will align with the other operating companies within the group.
"TVM UK has always been owned by the Dômes Pharma group, and since the start of our journey in the UK market we have been synonymous with expertise and outstanding levels of customer service in selected speciality segments of the animal health market and this won’t change.”
“Under the Dômes Pharma name we will continue to build and grow on this very strong foundation.
"I’m looking forward to working with the entire Dômes Pharma team as we increase our presence as a leading specialty pharmaceutical company, bringing our ethos to new speciality segments with innovative products and solutions for vets in the UK.
"Dômes Pharma remains a family-owned business, and the culture of the company really reflects this and we live by our values of kindness, boldness and responsibility.” https://www.domespharma.com https://www.tvm-uk.com
The new drug represents the fruit of 8 years of product development and more than 11 proprietary studies performed by Ceva R&D teams.
Marie Boutot, development project leader said: "Isemid is an original drug developed by Ceva, and was the subject of full pivotal efficacy and safety studies."
Ceva says the new drug has been recognised by the European Medicines Agency as a "2018 Innovation, advancing animal health".
Isemid is presented as pork-flavoured, scored tablets in three strengths: 1, 2 and 4 mg. They can be administered orally once daily, with or without food. The company's research showed a 98% owner compliance (compared to 92% for furosemide, p<0.05) and 80% voluntary acceptance.
Emilie Guillot, DVM, Ceva Technical Manager for Cardiology said: "With Isemid, we seek to help veterinarians in their goal to improve survival of dogs with heart failure.
"But above all, thanks to its potent action and long half-life which allow once-daily dosing, we hope to ease owner compliance."
Scientific communications with data on Isemid were presented at the American College of Veterinary Internal Medicine forum in Phoenix in June and will be held at the European College of Veterinary Internal Medicine congress in Milan in September.
VetSurgeon.org welcomed its 4000th member to the online community last night, and recorded it's 1 millionth page view since the site was first launched late in 2007.
Use of the site didn't really start to take off until after the installation of a state-of-the-art social networking software platform late in 2008, and the site is now well on target to reach it's 2 millionth page view well inside the next year.
There was another significant milestone last night when VetSurgeon.org was contacted by a solicitor and asked politely to remove a part of a forum post on the site. Unlike Private Eye, I don't have the resources to argue in court, so I removed the offending paragraph.
Whatever else, it's flattering that someone thinks the VetSurgeon community is now important enough to wheel out a solicitor. Still, I hope it doesn't become a regular occurance. It's something of a heart-stopping moment when the person at the other end of the telephone introduces themselves 'as the solicitor acting for ...'
Elle says she created the course she wished she had when she first qualified, one which offers provides practical tools and tailored support to build confidence, overcome self-doubt, and thrive in veterinary practice.
She said: “I remember what it felt like to step into practice as a newly qualified vet nurse—feeling unsure, overwhelmed, and constantly questioning whether I was good enough.
"That’s why I created this course - to give vet professionals the support and confidence they deserve.”
The Confidence Coaching CPD Course includes:
Elle says the course is ideal for both vets and vet nurses, in particular those struggling with confidence in their clinical skills, and professionals looking to progress in their careers.
The course costs £350, but as part of the launch, Elle is offering a 25% limited-time discount for those who sign up early using the code: PVN25.
https://thepositivevetnurse.com/cpd-course
Staffies were by far the most commonly stolen animal, accounting for 25.7% of all reported dogs thefts in the UK between 2017 and 2021.
Meanwhile, Devon and Cornwall had the highest number of pet thefts: 140.6 per 100,000 people.
Northumbria came second, with 61.5 pet thefts per 100,000 people, and Lancashire third (52.9 per 100,000).
On the other end of the scale, one breed that was less likely to be stolen was the pug (4.5%), although that's perhaps not surprising: after all, who'd want to steal an animal whose face you can't differentiate from its backside?
The safest animal in the country is probably an Akita (1.9%) living in Surrey (6.8 pet thefts per 100,000 people).
Full report: https://www.adt.co.uk/blog/the-adt-pet-theft-report
The BEVA has welcomed the news, whilst expressing its concern that the drug was suspended without consultation with the veterinary profession in the first place.
Jon Pycock, BEVA President said: "It remains a concern to BEVA that this mechanism was not put in place before the suspension of flunixin was imposed. Contrary to assertions by the VMD, wholesalers were unable to meet the demands of the veterinary profession and clinical use of this medicine was disrupted within 24 hours of the VMD’s initial announcement.
"We are surprised by the Regulator’s lack of awareness of availability in the supply chain and question why there was no consultation with the veterinary sector before the suspension was enacted. The VMD has been aware of this issue since March 2018 and it appears that no contingency was put in place to consider the animal welfare impact of this decision until it was too late."
BEVA Junior Vice President and Specialist in Equine Surgery Tim Mair continued: "Flunixin is a unique medicine in managing pain and sepsis in horses with colic. The VMD appeared to believe that this medicine could be substituted for other veterinary medicines and this is simply not the case. The release of stock from manufacturers is a short-term solution and, looking forward, we would like assurances that the VMD will fast track applications for the modification of product licenses to ensure that equine vets have continued access to these products."
Professor Kate White, Senior Vice President of the Association of Veterinary Anaesthetists added: "Provision of pain relief is essential to maintain animal welfare. The loss of these products would hinder the work of vets working with horses and donkeys and in zoos where they are first line drugs for the management of pain. Use of flunixin in these animals can be undertaken safely with no impact on human health."
Stock of flunixin held by manufacturers will be distributed alongside a ‘caution in use’ letter that will explain the restricted use of this product. BEVA is reminding all equine vets that the horse’s food chain status must be checked when using this product – either using the paper passport or the recently launched chip checker on the central equine database website.
The new devices are an evolution of the original v-gel device launched in 2012, which is widely used in veterinary anaesthesia and resuscitation.
Dr Muhammed Nasir, inventor of v-gel and President of Docsinnovent, said: "Our original product has proven to be extremely popular globally because it makes airway management easier; quicker; more comfortable for patients; and most importantly, safer for patients and staff.
"However, since launch our R&D team have been hard at work to make the devices even better. They are now slimmed down so that there is more room in the mouth for dentistry; they seal even better; and they are single-use, improving standards of hygiene"
Chris Geddes MRCVS, Docsinnovent’s Marketing Manager, added: "Our newly-launched website www.docsinnovent.com includes plentiful information on the new products including two hour-long CPD webinars from Dr Ivan Crotaz detailing how the new devices can be utilised for optimal airway management in anaesthetised patients.”
Information on where to buy the new products can be found at www.docsinnovent.com/distributors
Idexx says the new test is proven to identify kidney disease earlier than creatinine1–3, enabling veterinary surgeons to intervene earlier and have a greater impact on patients' health outcomes and quality of life.
The Catalyst SDMA Test was first launched at the company's reference laboratories in 2015, since when Idexx says it has run more than 14 million SDMA patient tests, creating the world's largest database on kidney disease in dogs and cats.
The test was then launched to veterinary practices in the USA and Canada last December, where Idexx says it has now been used by thousands of practices.
Jonathan Ayers, Chairman and Chief Executive Officer of Idexx Laboratories said: "We've seen great enthusiasm for the ability to run SDMA as part of the routine chemistry panel at the point of care, and the North American launch has exceeded our expectations.
"The Idexx SDMA Test represents one of the most significant diagnostic innovations in veterinary medicine in the last 30 years. We're thrilled to bring this essential element of the chemistry panel to our point of care Idexx VetLab suite, allowing veterinarians to utilize the benefits of SDMA immediately during the pet's appointment."
Idexx has also signed an agreement to collaborate with Yale University to explore the test's applications in human health. As a result of the partnership, the SDMA Test has been validated for accuracy in measuring SDMA in human blood samples and the results presented at the 2017 annual meeting of the American Society of Nephrology last November by Yale and IDEXX researchers.
Jonathan added: "SDMA has tremendous potential benefit in human applications as well. And with the Idexx test technology now validated to be able to run on commercial chemistry systems that routinely produce chemistry results in human reference laboratories, we have greater reason to explore the clinical value of this incredible biomarker in human applications. We are excited and grateful for our partnership with Yale University."
Idexx says SDMA is now the subject of more than 30 ongoing research collaborations and has been incorporated into the veterinary profession's International Renal Interest Society (IRIS) kidney disease staging guidelines.
For more information about the IDEXX Catalyst SDMA Test, visit www.idexx.eu/sdma.
References
Prior to the start of the hearing, the RCVS received correspondence from Mr Kombert confirming that he did not intend to attend the hearing, either in person or via a video-link, nor did he intend to send legal representation in his stead.
The Committee, chaired by Dr Martin Whiting, decided to proceed with the hearing in the absence of Mr Kombert and any legal representation, on the basis that it was in the public interest and the interests of justice to proceed and that Mr Kombert had been given the opportunity to attend or be represented.
The Committee heard that staff at the practice where Mr Kombert was working as a locum had undertaken a check of the medicines kept in the practice’s controlled drugs cabinet and discovered that 5.5ml of ketamine and 1.5ml of methadone was missing. After the code to the controlled drugs cabinet was changed, Mr Kombert was observed taking an additional 3ml of methadone, which he then administered to himself while on duty at the practice.
After Mr Kombert was confronted with the evidence, he was given the details of the Vetlife charity for support and asked not to return to the practice.
The police were contacted and, on 4 January 2019, Mr Kombert was arrested and interviewed. He received a police caution for theft, with conditions that he should attend and complete a drug-use awareness course, and engage in a restorative justice process, which involved attending the practice to discuss his offences. At this meeting, Mr Kombert admitted stealing the drugs and administering them to himself while on duty, which meant he was not in a fit state to see patients. He apologised for his actions and the matter was then also reported to the RCVS.
In relation to the fact that Mr Kombert had accepted the police caution, made the admissions at the restorative justice meeting and had emailed the RCVS apologising for his actions, the facts of the case were found proven.
The Committee then went on to consider if Mr Kombert’s actions amounted to disgraceful conduct in a professional respect (henceforth called ‘serious professional misconduct’), something which Mr Kombert had admitted to in correspondence with the RCVS.
The Committee found that Mr Kombert’s actions did amount to serious professional misconduct. Dr Martin Whiting, chairing the Committee and speaking on its behalf, said: "The respondent’s conduct was dishonest; it constituted both a breach of trust and an abuse of his position with regards to access to veterinary medicines; it risked animal welfare and jeopardised the reputation of colleagues. It fell far short of the conduct expected of a member of the profession and amounts to disgraceful conduct in a professional respect."
The Committee then considered what the appropriate sanction against Mr Kombert should be, taking into account both aggravating and mitigating factors.
In terms of aggravating factors, the Committee took into account the risk of harm to animals, his dishonesty, the premeditated nature of the misconduct, the breach of trust and the fact it was repeated.
It also took into account three previous matters recorded against Mr Kombert in the United States of America.
These were: a letter of admonition from the Colorado State Board of Veterinary Medicine for practising when his licence had expired; a stipulation order from the same body in which he agreed to relinquish his licence in that state following an allegation that he took controlled substances from a veterinary practice and self-administered them; and a criminal conviction in New York State for obtaining an opioid controlled drug by deception, for which he was sentenced to three years’ probation. The Committee was made aware of the New York State criminal conviction after Dianne Norris, a Probation Officer based in that state, had contacted the RCVS after hearing about the inquiry and informed the College that Mr Kombert was in breach of his probation conditions.
Dr Whiting said: “The Committee has considered the witness statement of Ms Dianne Norris, a probation officer employed by Putnam County Probation in New York, who was responsible for supervising the respondent as part of his probation. Ms Norris explained that the respondent breached his probation on numerous occasions, which took place from November 2017 to 2018…. As a result of the breaches, Ms Norris required the respondent to increase his attendance at support groups to an inpatient treatment program for 28 days from 13 July 2018. He failed to attend.
"Ms Norris explained that warrants were issued for the respondent’s arrest…. The Committee noted that the conduct of the respondent in relation to obtaining controlled drugs from his employers for his own use while in the United States of America was similar to his conduct … [described in] the charges."
In mitigation the Committee considered that Mr Kombert had consistently admitted the charges against him as well as accepting and agreeing with the evidence against him.
However, the Committee decided that in light of the seriousness of his misconduct, including dishonesty and risk of serious harm to animals, removal from the Register was the most appropriate and proportionate sanction.
Summing up, Dr Whiting said: "The respondent has failed to uphold the requisite standards to be expected of him on multiple occasions. The Committee considers that the only sanction that is sufficient to protect the welfare of animals, maintain public confidence in the profession and declare and uphold proper standards of conduct is one of erasure."
Mr Kombert has 28 days from being informed of the outcome of the hearing in which to make an appeal to the Privy Council.
The full facts and findings from the case can be found at www.rcvs.org.uk/disciplinary
Neuro orthopaedic veterinary surgeon Noel Fitzpatrick has been having a busy old time: hot on the heels of his world-first procedure to implant a prosthetic hip and femur in an American Bulldog comes the news that he has now fitted a cat with titanium prosthetic paws in another world-first.
Oscar the cat was minding his own business, basking in the late summer sun, when a passing combine harvester chopped off his hind paws.
Unlucky.
However, Oscar's luck turned when his veterinary surgeon, Peter Howarth from St Saviour in Jersey, referred owners Kate and Mike Nolan to Fitzpatrick Referrals to investigate the possibility of giving Oscar a pair of prosthetic paws.
Kate said: "We had to do a lot of soul-searching and our main concern has always been whether this operation would be in Oscar's best interests and would give him a better quality of life". Having decided it would, the Nolans asked Noel to go ahead. And so he came to give the two-year-old cat a pair of new artificial feet in a single, three-hour surgical procedure - something he says has never been done before by any team anywhere in the world.
The revolutionary design of the feet uses custom-made implants to 'peg' the ankle to the foot and mimics the way in which deer antler bone grows through skin. These pegs, or ITAPs (intraosseous transcutaneous amputation prosthetics), were first developed by a team from University College London led by Professor Gordon Blunn, Head of the Centre for Bio-Medical Engineering at UCL's Institute of Orthopaedics and Musculoskeletal Science. Working in partnership with UCL, Fitzpatrick has pioneered the use of these weight-bearing prosthetic implants.
During the operation, the veterinary surgical team had to insert the ITAPs by drilling into one of the ankle bones in each of the back legs - an extremely delicate feat, which could have fractured the ankle joint before the procedure had even begun, and even more challenging because it had to be performed twice. These artificial implants which are attached to the bone at an amputation site are coated with hydroxyapatite, which encourages bone cells to grow onto the metal. The skin then grows over the special umbrella at the end of the ITAP to form a resilient seal against bacteria and potentially fatal infections. The ITAP itself protrudes through the bone and skin, allowing the custom-built artifical paws to be attached securely. Click here to see x-rays and other case photos in the VetSurgeon media gallery.
Following successful surgery in November last year, the focus of the veterinary team has turned to the slow process of rehabilitation and helping Oscar to learn to walk again - firstly using external scaffolding anchored to the tibia to protect the new implants until the ITAPs integrated into the bone and the skin grew onto the ITAP. Remarkably Oscar was trying to stand within a day of the operation and despite some problems with infection that had to be overcome, in less than four months Oscar could stand and bear weight equally on all four limbs. He has since been fitted with a series of prototype new paws to ensure the best possible long term fit.
What makes this procedure so complicated is that Oscar's feet were severed at the junction of the tarsus and metatarsus. Noel said: "The real revolution with Oscar is because we have put a piece of metal and a flange into which skin grows into an extremely tight bone, with very narrow tolerances in the region of nanometres, rather than millimetres. We have then successfully managed to get the bone and skin to grow into the implant and we have developed an exoprosthesis that allows this implant to work as a see-saw on the bottom of an animal's limbs to give him effectively normal gait. Oscar can now run and jump about as cats should do.
Noel Fitzpatrick and the team at Fitzpatrick Referrals are the focus of a new six part documentary series: The Bionic Vet to be broadcast on BBC 1 at 10.45 pm every Wednesday starting on 30 June 2010. The programmes will focus on the multi million pound state-of-the-art vet practice in Surrey as well as the ways in which Noel is pioneering revolutionary new surgical techniques.
Eurovet Animal Health has launched Vomend, a new veterinary licensed metoclopramide that can be used to treat vomiting and reduced gastro-intestinal motility in both dogs and cats.
Eurovet says that for years, vets have often had little choice but to use metoclopramide preparations designed for human use - therefore effectively off-licence. This new preparation will allow vets to use a medication they know is of great benefit in treating dogs and cats, without taking all the additional precautions required for off-licence use, such as having clients sign consent forms.
The product can also be used in puppies and kittens. Severe vomiting in young puppies particularly can quickly lead to dehydration and depression, so it is vital to control the clinical signs and prevent fluid loss. Vomend will, according to the company, be particularly useful in this regard. As well as being an anti-emetic Vomend is also a pro-kinetic upper GI tract stimulant, so it is indicated for use in chronic nephritis, pyloric spasm and drug induced digestive intolerance.
Vomend will be available in 20 ml and 10 ml vials, providing greater flexibility over usage and stock control.
For further information on Vomend contact Eurovet on 01223 257933 or order direct from your wholesaler from early February.
Ed's note: The name. Is it just me? Wouldn't 'Tummyeaze' or something (anything) have been better?
Poulvac CVI + HVT Marek’s vaccine provides the combination of the Rispens CVI strain and the HVT strain.
Zoetis says this combination of serotypes has long been recognised for providing strong, reliable protection against the disease, effective even against the very virulent pathotype of the virus.
John Kenyon, Zoetis National Veterinary Manager for Poultry said: "Marek’s disease remains a major problem for the poultry industry.
"To increase protection, it is a good idea to combine the CVI and HVT vaccine strains, and the new supplies of our vaccine help to make this more feasible.
“Currently in some longer-lived broilers and backyard laying hens a vaccine composed of just a single serotype is used, but it is advantageous to use a combination of serotypes to boost immunity further.”
Marek’s vaccination with Poulvac CVI + HVT can be performed in the hatchery at day of age via subcutaneous or intramuscular injection.
The Zoetis vaccine is supported with a range of services, including hatchery and vaccine audits, vaccine training and technical assistance.
The Government has announced that from 6 April 2016 all dogs will be required to have a microchip.
This will give owners 3 years to comply with new legislation being drafted by Defra.
According to Defra, 100,000 dogs are dumped or lost each year at a cost of £57 million to the taxpayer and welfare charities. Only 60% of the 8 million dogs in the UK are currently chipped.
Making microchipping compulsory is intended to help reunite owners with lost or stolen pets, relieve the burden on animal charities and local authorities and protect the welfare of dogs by promoting responsible dog ownership.
Owners will be able to get their dog microchipped free at any of the 18 Dogs Trust centres around the UK, and free microchips will be offered by Dogs Trust to local authorities, housing associations and veterinary surgeries. In addition Battersea Dogs and Cats Home has announced that free microchipping will be offered at its three centres, and the Blue Cross will also offer free microchipping to dogs and cats at its 16 hospitals and centres across England.
Veterinary associations have hailed the introduction of compulsory microchipping for all dogs in England as a giant leap forward for dogs and their owners. BVA President Peter Jones said: "The introduction of compulsory microchipping is a giant leap for dogs and their owners and is something that vets have long campaigned for. Microchipping is a safe and effective way to link dogs to their owners and is an essential part of responsible ownership."
The Government also announced plans to extend the scope of the Dangerous Dogs Act to private places and to allow police to decide if dogs seized under the Act can stay with their owners until the outcome of the court case, removing the need for these dogs to be kennelled. Both of these measures were supported by BVA and BSAVA in joint responses to the Defra consultation.
The winning images were selected from nine finalists, shortlisted from hundreds of entries that were taken by vets, both in their professional and private lives.
And the winners are ...
Sophie said: “I was very surprised to win with my photo of a newborn calf standing next to me during the closing phases of surgery.
"I'm not that slow at suturing up, it’s just the calf was very alert and standing before I finished!
"For me this photo encapsulates the best parts of farm vetting: prompt decisions, safe handling, great outcomes, teamwork.
"I’m very proud to be a farm vet and exceptionally pleased this photo will be seen by current farm vets and hopefully will inspire future farm vets from all walks of life to pursue a veterinary career.”
Katherine, who is a third year Veterinary Medicine student at the Royal Veterinary College, said: “I'm absolutely delighted to have my photograph selected as the winner of the category, especially against such impressive entries.
"I was on a morning visit to a game reserve with a local vet in South Africa, when the sunrise highlighted the small oxpeckers on the backs of the giraffes, frantically flying to and fro.
"With the giraffe curiously watching us, I managed to capture the moment all three birds landed on its back, creating the image representing all creatures great and small.”
Sam Price said: "I took the image of my dog, Winnie, while on a campervan trip on the north coast of Ireland.
She loves nothing more than a beach day as you can see so I felt this was a fitting photo for the brief.
Thankfully there was a rare bout of sunshine on the day which made for some nice lighting and Winnie is pretty photogenic, which always helps!"
BVA President Malcolm Morley said: “The winning images stood out to us for many reasons, but we particularly liked how each one captured the essence of the category it was entered into; Sophie’s image of a c-section on a cow was so touching and really demonstrates the daily life of many of our valued farm vets; Katherine Edmondson’s photograph of the giraffe and red-billed oxpeckers was stunning but also truly embodied the All creatures great and small element; while Sam Price’s photo of Winnie the dog literally jumping for joy stole our hearts and genuinely made us all break out in smiles.
“Congratulations to all the winners, and also a huge well done to all the finalists as well, it was a really tough decision but you should be proud of the incredible photographs you entered and your talents.”
Hipra, a veterinary pharmaceutical company with subsidiaries in 19 countries, has opened in the UK and launched Eficur (ceftiofur hydrochloride).
Eficur is a ready to use injectable suspension for the treatment of bacterial respiratory disease associated with Mannheimia haemolytica, Pasteurella multocida and Histhophillus Somni in cattle and additionally Actinobacillus pleuropneumonia, Streptococcus suis and others in swine.
Eficur is also licensed for the treatment of acute interdigital necrobacillosis (panaritium, foot rot) and the bacterial component of acute post-partum (puerperal) metritis in cattle.
Eficur is available in a presentation of 50 ml, 100 ml and 250 ml. The 250 ml presentation also includes an innovative unbreakable protector.
For further information please contact: Hipra UK on 0115 812 0499 or uk@hipra.com, or visit www.hipra.com
The scheme will allow regular referrers to gift free treatment worth up to £5000 to clients in need of financial assistance
Hospital Director Nicola Bromley said: “We recognise the challenge it is for families who may need specialist care for their animal friend but are unable to find the necessary funds.
"We highly value the relationship we have with our referring vets in providing options to their clients, and we hope this scheme will empower them to give hope to those who need it most.
"We are committed to supporting our referring primary care vets through collaboration, to make the whole sector as good as it can be for every animal.”
The new scheme will be activated immediately and apply to referrals made from January 2024, meaning practices and primary care vets who already refer to Fitzpatrick Referrals can refer pro bono cases immediately.
https://www.fitzpatrickreferrals.co.uk
DISCUSSION
The research, carried out by PhD student, Dr Sarah Finnegan and a multidisciplinary team of neurologists, behaviourists and biologists, found that 65% of owners reported pre-seizure changes in their dog, most commonly clinginess, excessive energy, and unsettled sleep. These signs varied between dogs, with other common changes including clumsiness, excessive panting, becoming withdrawn or quiet, and lacking energy.
43% of owners also reported seizure triggers, which commonly involved stress, food and excitement. A wide range of other triggers were reported by owners including loud noises, fireworks, storms, household products (cleaning products and air freshener), and preventative healthcare including flea and worming products and vaccinations.
60% of owners believed they were able to predict an upcoming seizure in their dog by using a combination of pre-seizure changes and recognising triggers. Nearly half of these owners were able to do so 30 minutes or more before the seizure commenced.
Dr Rowena Packer, BBSRC Research Fellow and research lead in canine epilepsy at the RVC, said: "It was fascinating to discover how in-tune many owners of dogs with epilepsy are with subtle changes in their dog’s behaviour before seizures. Many of our findings echo what is seen in human epilepsy patients and add evidence to support the presence of prodromal pre-seizure periods in dogs as well as people.
"Collecting further objective data to confirm these findings and explore ways to proactively utilise this period for seizure management are of priority for future research.
“This study also highlights how crucial it is that owners of dogs with epilepsy keep good records, not just of their dog’s seizures, but also of changes in behaviour and exposure to potential triggers, to gain a better picture of patterns in their dog’s seizure activity. The RVC Pet Epilepsy Tracker app allows owners to keep records, that can also be shared electronically with their vet and with RVC for further research.”
Reference
Nat Whitley, clinical director at Davies Veterinary Services, said: "We are delighted to become part of the Linnaeus Group. We pride ourselves on delivering excellent service, so when the opportunity arose to become part of such a forward-thinking, impressive group it was a great match."
Emma Barnes, Linnaeus Group operations director, said: "We are very pleased to welcome Davies Veterinary Specialists to the Linnaeus family and look forward to combining their excellent work and care with our expertise, experience and support.
"We carefully select our partners in the Group to ensure the delivery of the highest quality of care and service across the entire business, which is why we are so pleased to have the Davies team on board."
Licensed for use from 6 weeks of age - and in pregnant and lactating bitches and queens - Evicto provides adulticidal, larvicidal and ovicidal flea protection, which can also help to control environmental flea infestations in areas where the pet has access. It also treats ear mites, biting lice, intestinal roundworms, sarcoptic mange in dogs, intestinal hookworms in cats and can be used to prevent heartworm disease with monthly administration.
Evicto is presented in packs of 4 pipettes which are transparent so owners can see that the full dose has been applied. The company also highlights that with Evicto pets can be bathed 2 hours after treatment without loss of efficacy.
Claire Lewis, Product Manager at Virbac said: "We are pleased to add Evicto to our award-winning range of parasite protection products.
"Evicto can also be used concurrently with Milpro, making it the perfect product partnership."
Evicto is available from the veterinary wholesalers now.
For information, speak to your Virbac Territory Manager.
Pawz Ltd, a UK company founded by Diwaker Singh, Radu Georgescu and Francesco Cardoletti has launched PawSquad, a new on-demand veterinary video consultation service for pet owners.
The service offers pet owners a 15 minute online consultation with a veterinary surgeon for £15, any time from 6:00am to midnight, seven days a week.
PawSquad points out that the service cannot offer a diagnosis - apart from the fact that it would be contrary to the CoPC, it's obviously not possible without a physical exam - so the service is designed to offer more general health advice concerning such things as behaviour, nutrition and the management of long-term, non-emergency conditions.
Andrew Francis BVSc CertVC, DipECVIM-CA MRCVS ex-Head of Cardiology at Anderson Moores Veterinary Referrals is the company's Chief Veterinary Officer, sitting alongside Andrew Ash MRCVS (the BSAVA Past Pres). Andrew #1 said: "Currently, pet owners have only two options when they need advice about their pets' health and welfare. They either take time out of busy schedules to visit the vet or, when a visit to the vet is not possible they search the Internet for non professional and frequently unreliable information."
Francesco Cardoletti said: "It’s important to understand that PawSquad is a supplementary service – it’s not replacing traditional veterinary services.There are limits to the services you can digitally provide. If an animal is seriously ill, it needs to get to a bricks and mortar veterinary clinic and be examined by a vet."
Eleanor Ferguson, Head of Professional Conduct at the RCVS said: "We have had a discussion with Pawsquad and understand that the aim of its service is to increase accessibility to veterinary advice, which can only be a good thing as a large percentage of animal owners are not registered with a veterinary surgeon.
“We understand that the veterinary surgeons involved will not be giving detailed clinical advice but will be limited to offering general advice on areas such as puppy care, nutrition, allergies and pet passports.
“We also recommended to Pawsquad that their veterinary surgeons should take care to point out the limitations of their advice, given no physical examination has taken place, and suggest that owners takes their pets to a veterinary practice where that is appropriate.
“The issue of telemedicine has come up often during the joint RCVS/BVA Vet Futures project and is a topic that the Standards Committee, which looks after the Code of Professional Conduct and its supporting guidance, is currently considering in more depth, with an evidence-gathering process due next year.”
I tried out the new service with a question about my dog's slightly worrying habit of growling at one of my children. It was a question which we had not thus far raised with our normal vet because it hadn't been enough of a concern at the last consultation. But it seems to be getting slightly worse, and my wife and I had recently talked about getting advice. It seemed like just the sort of situation where an informal chat with a vet could be helpful.
Completing the preconsultation details was a breeze, slowed only by the need to shove the dog on a set of scales (I didn't know what she weighs, and it's needed for the consultation). Thereafter, only one hiccup when it transpired that Safari, the browser I was using, is incompatible. I switched to Chrome, which is.
The consultation itself was excellent. Within a few seconds, the very charming Angie Henderson MRCVS appeared on my screen. It transpired I was her very first consultation since the service was launched yesterday! We discussed the problem. She reassured me that one of the things I was doing (getting the child to feed the dog under supervision) was a good idea, and we discussed a number of other positive reinforcement strategies to try and improve our dog's behaviour. She explained that she wasn't one for certain types of negative reinforcement, but that using a spray bottle of water when the dog behaved inappropriately could help. She explained that we would need to do these things several times a day for them to have an effect, and even then it may take some considerable time, and may need the services of a behaviourist. She also reassured me that the dog would be unlikely to do anything worse than nip, whilst stressing that even a nip is very upsetting for a child, so it does need to be dealt with.
All in all, I came away reassured, with some very useful suggestions and a clear idea of what we need to do. £15 very well spent. I gather that I should also have received a written post-consultation report by email, which didn't arrive because of some technical glitch. But that's slightly by-the-by; the icing on the cake.
I can also see the service would be very useful as a sort of out-of-hours triage, in other words offering me the ability to have a "my-dog-has-just-eaten-three-kilos-of-Green-and-Blacks-what-next-consultation?" at 11:00pm at night.
If the service proves popular amongst pet owners, the question remains whether it will reduce the number of people seeking and paying for traditional consultations. I suspect not. Perhaps the reverse will happen as pet owners use the system to corroborate their feeling that the dog might need a physical exam. As part of the service and with your permission, PawSquad forwards a copy of the consultation report to your normal vet.
Again if the service proves popular, it seems to offer the potential for a nice additional income stream for veterinary surgeons, especially locums, which can be earned in the hours you specify, from the comfort of your home. PawSquad says it pays vets between £12-£32 per hour; equivalent to £60K per annum. Whilst the company doesn't directly employ vets, it will provide liability insurance provided by the VDS.
PawSquad says it also plans to recruit veterinary nurses later in the year, to offer advice to new pet owners on nutrition, behaviour and the environment.
The new directive, set out in a consensus statement led by neurologist Dr Marios Charalambous, Neurology Consultant at Blaise Veterinary Referral Hospital, champions a stage-based and prompt approach which targets the abnormal impediments responsible for sustaining seizure activity and establishing refractory stages.
Marios said: "This consensus statement is the culmination of extensive research and experience in managing complex neurological emergencies.
"By formulating clear and universally applicable guidelines for all vets, it presents both a novel perspective in terms of how seizures should be treated, and a huge step forward in this specific field."
Marios was joined by a panel of clinicians including Karen Muñana, Ned E. Patterson, Simon R. Platt, and Holger A. Volk, who have jointly made these recommendations based on prevailing evidence in peer-reviewed literature, as well as their own extensive clinical experience.
It was then validated by the ACVIM Board-Certified Specialists before being distributed globally by ACVIM to form official guidelines for vets across the world.
Marios will be presenting and discussing his findings at the BSAVA Congress 2024 in Manchester this weekend as part of the neurology agenda on Saturday 23 March 2024.
Dan Lewis, National ECC Lead at IVC Evidensia, said: “Being presented with an actively seizing animal can be incredibly stressful for owners and clinicians and has potentially dire consequences.
"Decision-making under such circumstances is often very difficult, even for the most knowledgeable teams, and access to these straightforward treatment guidelines will make a massive difference to how these cases progress.”
https://onlinelibrary.wiley.com/doi/10.1111/jvim.16928.
The company says it is calling for the change after analysing the records of its consultations held during the pandemic and finding that there was a low antibiotic prescribing rate, treatments were effective and no harm was caused.
During the seven months that Vet-AI collected data, from the 1st April to the 31st October 2020, its vets held 21,383 veterinary video consultations, an analysis of which is the subject of a paper published in the RCVS Knowledge journal, Veterinary Evidence1.
78.1% of the consultations were for dogs and 21.9% for cats.
Of the vet-led video consultations completed, 3,541 had medicines prescribed during the consultation.
Some consultations required more than one prescription, which meant a total of 4,282 POM-V medications were prescribed.
Of those, Vet-AI says 0.87% reported a mild adverse effect.
Antibiotics were prescribed in 5.9% of all consultations, 99.3% of which was first line.
Vet AI says follow-up on prescribing was available in 67.7% of cases and 89.4% of all known treatment outcomes were complete or had an expected response to treatment.
Skin problems were the most common body system/disease category seen and prescribed for.
The remaining 17,482 consultations, which did not require a prescription medicine, had resolutions assigned.
They included 959 referrals to an emergency in-person veterinarian visit; 4,852 recommendations to visit a vet in-person; 4,216 alternative products recommended, 6,421 follow-up consultations with the remote veterinary team, and 219 remote laboratory tests.
Samantha Webster MRCVS (pictured right), from Joii Pet Care, said: “Given the clear evidence outlined in this report, we believe the future of veterinary medicine should include remote consultations with remote prescribing where appropriate and regulated.
"We invite the RCVS and other veterinary governing bodies to consider that there is a place for prescribing remotely on an ongoing basis for certain cases under certain conditions, such as a secure video and audio link with clinical record keeping and pharmacovigilance practice.
"A blanket ban is not appropriate with the advance of modern technology."
“Bold steps have been taken in human health, incorporating modern technologies to support both GPs and patients, to great success.
"Our industry could use these learnings to help reduce the current strain and demands on vets across the country where mental health is already a key issue due to increased pressures, under resourcing, and compassion fatigue.
“We feel it’s important to take this approach to reach as many owners and provide professional advice and appropriate treatment on pet health so that those animals that do not necessarily currently receive veterinary care do so, and to bridge the gap wanted by clients.”
A new range of food flavour sprays for dogs and cats, which could it a lot easier for vets, nurses and owners to feed reluctant eaters and administer oral medications, has been launched by M H Foods Ltd.
The sprays, which will retail through veterinary practices only, are primarily designed to encourage cats and dogs to eat in situations where they are reluctant to feed.
Testimonials received by the company from vets and veterinary hospitals suggest the sprays may help pets to eat when recovering from surgery or suffering from anxiety or depression. The company says they have also been helpful in encouraging pets to eat before their insulin injections and to enjoy bland foods such as renal diets.
Fred Key, Managing Director of M H Foods, said: "The well-researched aromas and flavours of this patented development, which we have branded Bon Appetit, entice pets back to eating. Another plus, pointed out by veterinary nurses, is that our flavour sprays disguise tablets and medication powder on food, making life easier for pets and owners alike!
"The Bon Appetit range - in chicken, beef and fish varieties - is artificially flavoured and, therefore, has no protein and is free from sodium, potassium and phosphorous, adding only 2 Cals per spray".
Retailing at around £5 to £6 for about 50 days' supply, M H Foods says that Bon Appetit has been well received by the major veterinary wholesalers.
Testimonials, full product and analytical information is available at: http://www.mh-foods.co.uk/.
Merial has announced the launch of NexGard Spectra, a broad spectrum oral parasiticide for dogs.
NexGard Spectra contains afoxolaner, which kills fleas and ticks on dogs, and milbemycin oxime, which is effective against roundworms, hookworms and whipworms.
The new product is delivered in a beef flavoured chew to help compliance.
NexGard Spectrum is available in five different weight ranges to suit puppies and dogs of all sizes.
Dechra says Finilac inhibits prolactin secretion by the pituitary gland and therefore inhibits all prolactin-dependent processes, meaning it can also suppress lactation in bitches and queens.
Finilac, which contains cabergoline (50 microgram/ml), is presented as a liquid which can be given orally or in food. It is available in 3 ml, 10 ml, 15 ml and 25 ml bottles with 1 ml and 2.5 ml syringes included in every pack to ensure accurate dosing.
The dosage is 0.1 ml/kg bodyweight once daily for four to six consecutive days, depending on the severity of the clinical condition. Maximum inhibition of prolactin secretion is achieved after four to eight hours.
Dechra Brand Manager Carol Morgan said: "A false pregnancy can be a distressing condition for an animal and its owner so Finilac offers a fresh approach for cases with more severe symptoms that require veterinary intervention.
"It is easy to administer either directly into the mouth or by mixing with food and it doesn’t need to be transported or stored in the refrigerator, making it ideal as an ‘at home’ treatment that can be administered by owners."